U.S.FDAApprovesExpandedIndicationforVONVENDI[vonWillebrandfactor(Recombinant)]forAdultsandChildrenwithVonWillebrandDisease
===2025/9/8 13:05:41===
l and Prevention website. Accessed July 9, 2025.https://www.cdc.gov/von-willebrand/about/?CDC_AAref_Val=https://www.cdc.gov/ncbddd/vwd/facts.html
Nicholas L.J. Chornenki, Edwin Ocran, Paula D. James; Special considerations in GI bleeding in VWD patients. Hematology Am Soc Hematol Educ Program 2022; 2022 (1): 624–630. doi:https://doi.org/10.1182/hematology.2022000390
Contacts
Media Contact
Lindsey Colegrove
Lindsey.Colegrove@takeda.com
+1 617 306 5718
=*=*=*=*=*=
当前为第17/17页
上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页